Table 4 Estimated probabilities (%) of morbidity and mortality from untreated SNPTB and side effects in treated SNPTB (median and inter quartile range)
|  |  | India (n = 77) | Pakistan (n = 84) | Bangladesh (n = 81) | All countries (n = 242) |
|---|---|---|---|---|---|
1 | Mortality from untreated SNPTB* | 70 (65-75) | 60 (30-82.5) | 60 (40-70) | 65 (50-75) |
2 | Morbidity from untreated SNPTB¶ | 5 (5-10) | 20 (10-30) | 29.5 (20-30) | 20 (8-30) |
3 | Probability of side effects occurring if SNPTB is treated¶ | 6 (3-9) | 10 (5-20) | 15 (10-29) | 10 (5-20) |
4 | Conditional probability of death due to side effects if they occur when SNPTB is treated¶ | 5 (3-5) | 10 (4.5-20) | 12.5 (5-25) | 8 (5-20) |
5 | Conditional probability of morbidity as a result of side effects when SNPTB is treated¶ | 10 (7-15) | 25 (10-50) | 15 (10-30) | 15 (10-30) |
6 | Absolute probability of mortality arising from side effects of anti-TB treatment¶× | 0.25 (0.11-0.45) | 1.5 (0.71-10) | 1(0.22-4.0) | 0.70 (0.23-3.1) |
7 | Absolute probability of morbidity arising from side effect of anti-TB treatment¶π | 0.6 (0.3-1) | 3.0 (1-7.4) | 3 (0.57-8) | 1.5 (0.6-4.6) |